These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 26068641
1. Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors. Seiler SM, Baumgartner C, Hirschberger J, Beer AJ, Brühschwein A, Kreutzmann N, Laberke S, Wergin MC, Meyer-Lindenberg A, Brandl J, von Thaden AK, Farrell E, Schwaiger M. PLoS One; 2015; 10(6):e0127800. PubMed ID: 26068641 [Abstract] [Full Text] [Related]
5. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J. Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558 [Abstract] [Full Text] [Related]
7. Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography. Brody A, Crooks JC, French JM, Lang LG, Randall EK, Griffin LR. Vet Comp Oncol; 2022 Sep; 20(3):541-550. PubMed ID: 35166445 [Abstract] [Full Text] [Related]
8. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions. Ozcan Kara P, Kara T, Kara Gedik G, Kara F, Sahin O, Ceylan Gunay E, Sari O. Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046 [Abstract] [Full Text] [Related]
9. FDG-PET/CT in the evaluation of anal carcinoma. Cotter SE, Grigsby PW, Siegel BA, Dehdashti F, Malyapa RS, Fleshman JW, Birnbaum EH, Wang X, Abbey E, Tan B, Kodner IJ, Hunt SR, Lowney JK, Mutch MG, Dietz DW, Myerson RJ. Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):720-5. PubMed ID: 16626889 [Abstract] [Full Text] [Related]
13. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer. Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS. PLoS One; 2014 Jul 01; 9(12):e115127. PubMed ID: 25517451 [Abstract] [Full Text] [Related]
14. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Facey K, Bradbury I, Laking G, Payne E. Health Technol Assess; 2007 Oct 01; 11(44):iii-iv, xi-267. PubMed ID: 17999839 [Abstract] [Full Text] [Related]
15. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer. Groheux D, Hindié E, Marty M, Espié M, Rubello D, Vercellino L, Bousquet G, Ohnona J, Toubert ME, Merlet P, Misset JL. Eur J Radiol; 2014 Oct 01; 83(10):1925-33. PubMed ID: 24985086 [Abstract] [Full Text] [Related]
16. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Ann Surg; 2009 Dec 01; 250(6):957-63. PubMed ID: 19687736 [Abstract] [Full Text] [Related]
18. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, Masseau A, Bernard F, Berthelot JM, Morel N, Lifermann F, Palat S, Haroche J, Mariette X, Godeau B, Bernit E, Costedoat-Chalumeau N, Papo T, Hamidou M, Harlé JR, Schleinitz N. Arthritis Care Res (Hoboken); 2014 Jan 01; 66(1):86-96. PubMed ID: 23836437 [Abstract] [Full Text] [Related]
19. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Kim HJ, Cho A, Yun M, Kim YT, Kang WJ. Ann Nucl Med; 2016 Feb 01; 30(2):104-13. PubMed ID: 26546334 [Abstract] [Full Text] [Related]